Antibiotics
1.1 Introduction
1.2 Classification of antibiotics
1.3 Production of antibiotics
1.4 Mechanism of action
methods
2. Vaccine
2.1 Definition
2.2 Types of vaccines
2.3 Types of manufacturing
2.4 Mechanism of action
The following presentation is only for quick reference. I would advise you to read the theoretical aspects of the respective topic and then use this presentation for your last minute revision. I hope it helps you..!!
Mayur D. Chauhan
Single Cell Protein -slideshare ppt
tag
,
single cell protein slideshare
,
single cell protein
,
flowchart of single cell protein production
,
single cell protein pdf
,
single cell protein production ppt
The following presentation is only for quick reference. I would advise you to read the theoretical aspects of the respective topic and then use this presentation for your last minute revision. I hope it helps you..!!
Mayur D. Chauhan
Single Cell Protein -slideshare ppt
tag
,
single cell protein slideshare
,
single cell protein
,
flowchart of single cell protein production
,
single cell protein pdf
,
single cell protein production ppt
Strain improvement Part II, Generation of mutants producing high level of pri...Renu Jaisinghani
This presentation, describes about various mutants that can be generated by carrying out process of mutation, so that high yielding mutants can be obtained that can be used for industrial production of primary metabolite.
This presentation about the glance of industrial production and application of antibiotics useful for learner who quikly understand the antibiotics production and their uses.
Basic Knowledge about industrial microorganism. why industry choose microorganism rather than chemical. isolation technique of microorganism. source of microorganisms. Process of using microorganism. Disadvantages of using microorganisms in industry. Process of genetic modification of microorganisms. Storage process of microorganism. preservation methods of microorganism. Reculture methods of microorganism.
Generally, organic acids are produced commercially either by chemical synthesis or fermentation. ... All organic acids of tricarboxylic acid cycle can be produced in high yields in microbiological processes. Among fermentation processes, the production of organic acids is dominated by submerged fermentation.
Strain improvement Part II, Generation of mutants producing high level of pri...Renu Jaisinghani
This presentation, describes about various mutants that can be generated by carrying out process of mutation, so that high yielding mutants can be obtained that can be used for industrial production of primary metabolite.
This presentation about the glance of industrial production and application of antibiotics useful for learner who quikly understand the antibiotics production and their uses.
Basic Knowledge about industrial microorganism. why industry choose microorganism rather than chemical. isolation technique of microorganism. source of microorganisms. Process of using microorganism. Disadvantages of using microorganisms in industry. Process of genetic modification of microorganisms. Storage process of microorganism. preservation methods of microorganism. Reculture methods of microorganism.
Generally, organic acids are produced commercially either by chemical synthesis or fermentation. ... All organic acids of tricarboxylic acid cycle can be produced in high yields in microbiological processes. Among fermentation processes, the production of organic acids is dominated by submerged fermentation.
Contents
IntroductionWhat are vaccine?
History of vaccineIdeal properties of vaccine.
Mechanism of vaccine
Types of vaccineUptake of antigen
Single shot vaccine
Mucosal delivery vaccine
Transdermal delivery vaccineReferences
Vaccines are tiny fragments of the disease-causing organism or the blueprints for making the tiny fragments. They contain other ingredients to keep the vaccine safe and effective.
The word Fermentation is derived from Latin word fervere which means to boil.
But the conventional definition of Fermentation is to break down of larger molecules into smaller and simple molecules using microorganisms.
In Biotechnology, Fermentation means any process by which microorganisms are grown in large quantities to produce any type of useful materials.
Preparation and quality control of immunological productsMayur D. Chauhan
The following presentation is only for quick reference. I would advise you to read the theoretical aspects of the respective topic and then use this presentation for your last minute revision. I hope it helps you..!!
Mayur D. Chauhan
Antimicrobial agent is a substance that interferes with the growth and activity of microorganisms.
These agents inhibit or kill microorganisms. Some antimicrobial agents are used to fight against infections and are called Chemotherapeutic Agents
A unique characteristic of an antimicrobial agent is selective toxicity, that is, it will destroy the organism but not affect the host
Introduction, Issues on GM Food, Health issues and food safety, Changing God’s creation and tampering with nature, Al-Qur’an and Al-hadith views regarding GM foods and products, Al-Qur’an and Al-hadith points of views regarding the issue of changing God's creation
Introduction
METHODS USED IN PLANT DISEASE MANAGEMENT
Cultural method
Biological control method
Breeding method for disease resistance
TYPES OF RESISTANCE
CONCEPT OF RESISTANCE
The increased availability of biomedical data, particularly in the public domain, offers the opportunity to better understand human health and to develop effective therapeutics for a wide range of unmet medical needs. However, data scientists remain stymied by the fact that data remain hard to find and to productively reuse because data and their metadata i) are wholly inaccessible, ii) are in non-standard or incompatible representations, iii) do not conform to community standards, and iv) have unclear or highly restricted terms and conditions that preclude legitimate reuse. These limitations require a rethink on data can be made machine and AI-ready - the key motivation behind the FAIR Guiding Principles. Concurrently, while recent efforts have explored the use of deep learning to fuse disparate data into predictive models for a wide range of biomedical applications, these models often fail even when the correct answer is already known, and fail to explain individual predictions in terms that data scientists can appreciate. These limitations suggest that new methods to produce practical artificial intelligence are still needed.
In this talk, I will discuss our work in (1) building an integrative knowledge infrastructure to prepare FAIR and "AI-ready" data and services along with (2) neurosymbolic AI methods to improve the quality of predictions and to generate plausible explanations. Attention is given to standards, platforms, and methods to wrangle knowledge into simple, but effective semantic and latent representations, and to make these available into standards-compliant and discoverable interfaces that can be used in model building, validation, and explanation. Our work, and those of others in the field, creates a baseline for building trustworthy and easy to deploy AI models in biomedicine.
Bio
Dr. Michel Dumontier is the Distinguished Professor of Data Science at Maastricht University, founder and executive director of the Institute of Data Science, and co-founder of the FAIR (Findable, Accessible, Interoperable and Reusable) data principles. His research explores socio-technological approaches for responsible discovery science, which includes collaborative multi-modal knowledge graphs, privacy-preserving distributed data mining, and AI methods for drug discovery and personalized medicine. His work is supported through the Dutch National Research Agenda, the Netherlands Organisation for Scientific Research, Horizon Europe, the European Open Science Cloud, the US National Institutes of Health, and a Marie-Curie Innovative Training Network. He is the editor-in-chief for the journal Data Science and is internationally recognized for his contributions in bioinformatics, biomedical informatics, and semantic technologies including ontologies and linked data.
Professional air quality monitoring systems provide immediate, on-site data for analysis, compliance, and decision-making.
Monitor common gases, weather parameters, particulates.
A brief information about the SCOP protein database used in bioinformatics.
The Structural Classification of Proteins (SCOP) database is a comprehensive and authoritative resource for the structural and evolutionary relationships of proteins. It provides a detailed and curated classification of protein structures, grouping them into families, superfamilies, and folds based on their structural and sequence similarities.
Slide 1: Title Slide
Extrachromosomal Inheritance
Slide 2: Introduction to Extrachromosomal Inheritance
Definition: Extrachromosomal inheritance refers to the transmission of genetic material that is not found within the nucleus.
Key Components: Involves genes located in mitochondria, chloroplasts, and plasmids.
Slide 3: Mitochondrial Inheritance
Mitochondria: Organelles responsible for energy production.
Mitochondrial DNA (mtDNA): Circular DNA molecule found in mitochondria.
Inheritance Pattern: Maternally inherited, meaning it is passed from mothers to all their offspring.
Diseases: Examples include Leber’s hereditary optic neuropathy (LHON) and mitochondrial myopathy.
Slide 4: Chloroplast Inheritance
Chloroplasts: Organelles responsible for photosynthesis in plants.
Chloroplast DNA (cpDNA): Circular DNA molecule found in chloroplasts.
Inheritance Pattern: Often maternally inherited in most plants, but can vary in some species.
Examples: Variegation in plants, where leaf color patterns are determined by chloroplast DNA.
Slide 5: Plasmid Inheritance
Plasmids: Small, circular DNA molecules found in bacteria and some eukaryotes.
Features: Can carry antibiotic resistance genes and can be transferred between cells through processes like conjugation.
Significance: Important in biotechnology for gene cloning and genetic engineering.
Slide 6: Mechanisms of Extrachromosomal Inheritance
Non-Mendelian Patterns: Do not follow Mendel’s laws of inheritance.
Cytoplasmic Segregation: During cell division, organelles like mitochondria and chloroplasts are randomly distributed to daughter cells.
Heteroplasmy: Presence of more than one type of organellar genome within a cell, leading to variation in expression.
Slide 7: Examples of Extrachromosomal Inheritance
Four O’clock Plant (Mirabilis jalapa): Shows variegated leaves due to different cpDNA in leaf cells.
Petite Mutants in Yeast: Result from mutations in mitochondrial DNA affecting respiration.
Slide 8: Importance of Extrachromosomal Inheritance
Evolution: Provides insight into the evolution of eukaryotic cells.
Medicine: Understanding mitochondrial inheritance helps in diagnosing and treating mitochondrial diseases.
Agriculture: Chloroplast inheritance can be used in plant breeding and genetic modification.
Slide 9: Recent Research and Advances
Gene Editing: Techniques like CRISPR-Cas9 are being used to edit mitochondrial and chloroplast DNA.
Therapies: Development of mitochondrial replacement therapy (MRT) for preventing mitochondrial diseases.
Slide 10: Conclusion
Summary: Extrachromosomal inheritance involves the transmission of genetic material outside the nucleus and plays a crucial role in genetics, medicine, and biotechnology.
Future Directions: Continued research and technological advancements hold promise for new treatments and applications.
Slide 11: Questions and Discussion
Invite Audience: Open the floor for any questions or further discussion on the topic.
3. HEALTH CARE PRODUCTS
• CONTENTS
1. Antibiotics 2. Vaccine
1.1 Introduction 2.1 Definition
1.2 Classification of antibiotics 2.2 Types of vaccines
1.3 Production of antibiotics 2.3 Types of manufacturing
1.4 Mechanism of action methods
2.4 Mechanism of action
3
4. HEALTH CARE PRODUCTS
• 1. Antibiotics
• 1.1 Introduction
• Antibiotics are chemical substances that can inhibit the growth of or destroy
microorganism
• They are from derived from special microorganism
• They are produced on industrial scale by fermentation
• Antibiotic may be bactericidal or may be bacteriostatic
4
5. HEALTH CARE PRODUCTS
• 1.2 Classification of antibiotics
• There are several classification schemes for antibiotics
• Based on bacterial spectrum (broad versus narrow)
• Route of administration (injectable versus oral)
• Type of activity (bactericidal versus bacteriostatic)
5
6. HEALTH CARE PRODUCTS
• 1.2 Classification of antibiotics
• Major groups of antibiotics may be the following types:
• Penicillin's
• Cephalosporin's
• Fluroquinolones
• Tetracycline's
• Macrolides
6
7. HEALTH CARE PRODUCTS
• 1.2 Classification of antibiotics
• Other classes of antibiotics include the aminoglycosides
• This is particularly useful for their effectiveness in treating Pseudomonas
aeruginosa infection
• Lincosamindes, clindamycin and lincomycin are highly active against anaerobic
pathogens
7
8. HEALTH CARE PRODUCTS
• 1.3 Production of antibiotics
• Its is very critical
• Antibiotics are secretions from certain strain of bacteria to restrict growth of other
bacteria around them
• Production of antibiotic can be done by three methods
1. Natural microbial production using fermentation technology
2. Semi synthetic production
3. Synthetic production of antibiotics
8
9. HEALTH CARE PRODUCTS
• 1.3.1 Industrial production technique
• Antibiotics are produced industrially by a process of fermentation
• Microorganism is grown in large containers (100,000-150,000 liters or more)
containing a liquid growth medium
• Oxygen concentration, pH, temperature and nutrient levels must be optimal
• Antibiotics are secondary metabolites, the population size must be controlled for
maximum yield production before cells die
9
10. HEALTH CARE PRODUCTS
• 1.3.2 Strains used for production
• Microorganism used in fermentation are rarely identical to the wild type
• Species are genetically modified to yield the maximum amounts of antibiotics
• Mutation is often used encouraged by introducing mutagens such as ultraviolet
radiation, x-rays or certain chemicals
• Another technique used to increase yields is gene amplification
• Copies of genes coding enzymes involved in the antibiotic production can be
inserted back in to a cell, via vectors such as plasmids
10
11. HEALTH CARE PRODUCTS
• 1.3.3 Production of antibiotics by fermentation
1. A pure culture of the chosen organism, in sufficient quantity and in the correct
physiological state
2. Sterilized, carefully composed medium for growth of the organism
3. A seed fermenter, a mini-model of production fermenter to develop inoculums
to initiate the process in the main fermenter
11
12. HEALTH CARE PRODUCTS
• 1.3.3 Production of antibiotics by fermentation
4. A production fermenter, the functional large model and equipment for
a) Drawing the culture medium in steady state
b) Cell separation
c) Collection of cell free supernatant
d) Product purification
12
13. HEALTH CARE PRODUCTS
• 1.3.3 Production of antibiotics by fermentation
Figure1.3.3 Example of antibiotics produce by different microorganism (Google)
Antibiotics Producing microbes
Cephalosporin Cephalosporium acrimonium
Chloramphenicol Streptomyces venezulae
Erythromycin Streptomyces erythreus
Griseofulvin Penicillium griseofulvin
Gentamicin Micromonospora purpurea
13
14. HEALTH CARE PRODUCTS
• 1.4 Mechanism of action
• The term mechanism of action (MOA) refers to the specific biochemical
interaction
• Through which a drug substance produces its pharmacological effect
• A mechanism of action usually includes mention of the specific molecular targets
to which the drug binds, such as an enzyme or receptor
14
15. HEALTH CARE PRODUCTS
• 1.4 Mechanism of action
• For example, β-Lactam antibiotics are bacteriocidal
• It acts by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls
• The final step in the synthesis of the peptidoglycan is facilitated by penicillin-
binding proteins (PBPs)
• Penicillin bind with penicillin-binding proteins (PBPs) become activated and
destroy the peptide bridge between amino sugar of cell wall
15
16. HEALTH CARE PRODUCTS
• 1.4 Mechanism of action
• Penicillin kills susceptible bacteria by specifically inhibiting the transpeptidase
• Transpeptidase catalyzes the final step in cell wall biosynthesis, the cross-linking
of peptidoglycan
16
17. HEALTH CARE PRODUCTS
• 2. Vaccine
• 2.1 Definition
• An antigenic substance prepared from the causative agent of a disease or a
synthetic substitute, used to provide immunity against one or several diseases
(or)
• A vaccine is a substance containing a harmless form of the germs that cause a
particular disease. It is given to people, usually by injection,
to prevent them getting that disease
17
18. HEALTH CARE PRODUCTS
• 2.2 Types of vaccine
• There are two types of vaccines available in the market
2.2.1 Non-adjuvanted vaccines
2.2.2 Adjuvanted vaccines
18
19. HEALTH CARE PRODUCTS
• 2.2 Types of vaccine
2.2.1 Non-adjuvanted vaccines
• It has only the antigen as its main component
• Examples, rabies vaccine
2.2.2 Adjuvant vaccines
• It has two main components, the antigen and the adjuvant
• Examples, hepatitis A, hepatitis B and diphtheria tetanus
19
20. HEALTH CARE PRODUCTS
• 2.3 Types of Vaccine Manufacturing Methods
• There are different methods used to produce vaccines
2.3.1 Traditional method using eggs
2.3.2 New methods using mammalian cells
20
21. HEALTH CARE PRODUCTS
• 2.3.1 Egg-Based Vaccine
• Over the last 60 years, seasonal flu vaccines have been manufactured using
fertilized embryonic eggs
• Using this method, it takes about four months to produce a batch of vaccines for a
new strain of influenza virus
• Advantage of using embryonic egg to manufacture seasonal flu vaccines
• Also produce effectiveness vaccines via embryonic egg
21
22. HEALTH CARE PRODUCTS
• 2.3.2 Cell- Based Vaccines
• In this method, cells used from mammals to culture the influenza virus for vaccine
production
• Various pharmaceutical companies use different sources of mammalian cell
culture for vaccine production
• Baxter Health care uses cells extracted from the kidney of African Green Monkey
22
23. HEALTH CARE PRODUCTS
• 2.4 Mechanism of action
• Function of vaccine is to enhance our natural defense system i.e. our immune
system, to fight and defend our body against disease
• When vaccine is injected into our body, it will trigger an immune response in same
way our body respond after exposure to virus
• Our immune system detect and recognize the antigen in vaccine as foreign invader
23
24. HEALTH CARE PRODUCTS
• 2.4 Mechanism of action
• So immune system will start immune response to produce protein called
antibodies
• Antibodies neutralized these foreign invader
• If our body come in contact with same virus in future, our immune system should
be able to respond fast enough to prevent the development of disease
24